Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development
Open Access
- 9 March 2011
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Medicinal Chemistry Journal
- Vol. 5 (1), 31-39
- https://doi.org/10.2174/1874104501105010031
Abstract
Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and DevelopmentKeywords
This publication has 103 references indexed in Scilit:
- N-(2-hydroxypropyl)methacrylamide–amphotericin B (HPMA–AmB) copolymer conjugates as antileishmanial agentsInternational Journal of Antimicrobial Agents, 2009
- Paromomycin: Uptake and resistance in Leishmania donovaniMolecular and Biochemical Parasitology, 2009
- Genomic-scale prioritization of drug targets: the TDR Targets databaseNature Reviews Drug Discovery, 2008
- Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis PatientsAntimicrobial Agents and Chemotherapy, 2008
- Antiparasitic compounds that target DNABiochimie, 2008
- Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline SuccinateAntimicrobial Agents and Chemotherapy, 2008
- Target assessment for antiparasitic drug discoveryTrends in Parasitology, 2007
- Quinuclidine Derivatives as Potential AntiparasiticsAntimicrobial Agents and Chemotherapy, 2007
- Transmission of Leishmania metacyclic promastigotes by phlebotomine sand fliesInternational Journal for Parasitology, 2007
- Miltefosine Affects Lipid Metabolism in Leishmania donovani PromastigotesAntimicrobial Agents and Chemotherapy, 2007